Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients

Ribosomal RNA (rRNA), the most abundant non-coding RNA species, is a major component of the ribosome. Impaired ribosome biogenesis causes the dysfunction of protein synthesis and diseases called “ribosomopathies,” including genetic disorders with cancer risk. However, the potential role of rRNA gene...

Full description

Bibliographic Details
Main Authors: Riuko Ohashi, Hajime Umezu, Ayako Sato, Tatsuya Abé, Shuhei Kondo, Kenji Daigo, Seijiro Sato, Norikazu Hara, Akinori Miyashita, Takeshi Ikeuchi, Teiichi Motoyama, Masashi Kishi, Tadahiro Nagaoka, Keiko Horiuchi, Atsushi Shiga, Shujiro Okuda, Tomoki Sekiya, Aya Ohtsubo, Kosuke Ichikawa, Hiroshi Kagamu, Toshiaki Kikuchi, Satoshi Watanabe, Jun-Ichi Tanuma, Peter Schraml, Takao Hamakubo, Masanori Tsuchida, Yoichi Ajioka
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/11/2409
id doaj-bbb0d54a6cf148f4a62a2177a1c8183c
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Riuko Ohashi
Hajime Umezu
Ayako Sato
Tatsuya Abé
Shuhei Kondo
Kenji Daigo
Seijiro Sato
Norikazu Hara
Akinori Miyashita
Takeshi Ikeuchi
Teiichi Motoyama
Masashi Kishi
Tadahiro Nagaoka
Keiko Horiuchi
Atsushi Shiga
Shujiro Okuda
Tomoki Sekiya
Aya Ohtsubo
Kosuke Ichikawa
Hiroshi Kagamu
Toshiaki Kikuchi
Satoshi Watanabe
Jun-Ichi Tanuma
Peter Schraml
Takao Hamakubo
Masanori Tsuchida
Yoichi Ajioka
spellingShingle Riuko Ohashi
Hajime Umezu
Ayako Sato
Tatsuya Abé
Shuhei Kondo
Kenji Daigo
Seijiro Sato
Norikazu Hara
Akinori Miyashita
Takeshi Ikeuchi
Teiichi Motoyama
Masashi Kishi
Tadahiro Nagaoka
Keiko Horiuchi
Atsushi Shiga
Shujiro Okuda
Tomoki Sekiya
Aya Ohtsubo
Kosuke Ichikawa
Hiroshi Kagamu
Toshiaki Kikuchi
Satoshi Watanabe
Jun-Ichi Tanuma
Peter Schraml
Takao Hamakubo
Masanori Tsuchida
Yoichi Ajioka
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients
Cells
lung adenocarcinoma
rDNA
ribosome biogenesis
single nucleotide variant
prognosis
author_facet Riuko Ohashi
Hajime Umezu
Ayako Sato
Tatsuya Abé
Shuhei Kondo
Kenji Daigo
Seijiro Sato
Norikazu Hara
Akinori Miyashita
Takeshi Ikeuchi
Teiichi Motoyama
Masashi Kishi
Tadahiro Nagaoka
Keiko Horiuchi
Atsushi Shiga
Shujiro Okuda
Tomoki Sekiya
Aya Ohtsubo
Kosuke Ichikawa
Hiroshi Kagamu
Toshiaki Kikuchi
Satoshi Watanabe
Jun-Ichi Tanuma
Peter Schraml
Takao Hamakubo
Masanori Tsuchida
Yoichi Ajioka
author_sort Riuko Ohashi
title Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients
title_short Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients
title_full Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients
title_fullStr Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients
title_full_unstemmed Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients
title_sort frequent germline and somatic single nucleotide variants in the promoter region of the ribosomal rna gene in japanese lung adenocarcinoma patients
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2020-11-01
description Ribosomal RNA (rRNA), the most abundant non-coding RNA species, is a major component of the ribosome. Impaired ribosome biogenesis causes the dysfunction of protein synthesis and diseases called “ribosomopathies,” including genetic disorders with cancer risk. However, the potential role of rRNA gene (rDNA) alterations in cancer is unknown. We investigated germline and somatic single-nucleotide variants (SNVs) in the rDNA promoter region (positions −248 to +100, relative to the transcription start site) in 82 lung adenocarcinomas (LUAC). Twenty-nine tumors (35.4%) carried germline SNVs, and eight tumors (9.8%) harbored somatic SNVs. Interestingly, the presence of germline SNVs between positions +1 and +100 (<i>n</i> = 12; 14.6%) was associated with significantly shorter recurrence-free survival (RFS) and overall survival (OS) by univariate analysis (<i>p</i> < 0.05, respectively), and was an independent prognostic factor for RFS and OS by multivariate analysis. LUAC cell line PC9, carrying rDNA promoter SNV at position +49, showed significantly higher ribosome biogenesis than H1650 cells without SNV. Upon nucleolar stress induced by actinomycin D, PC9 retained significantly higher ribosome biogenesis than H1650. These results highlight the possible functional role of SNVs at specific sites of the rDNA promoter region in ribosome biogenesis, the progression of LUAC, and their potential prognostic value.
topic lung adenocarcinoma
rDNA
ribosome biogenesis
single nucleotide variant
prognosis
url https://www.mdpi.com/2073-4409/9/11/2409
work_keys_str_mv AT riukoohashi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT hajimeumezu frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT ayakosato frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT tatsuyaabe frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT shuheikondo frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT kenjidaigo frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT seijirosato frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT norikazuhara frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT akinorimiyashita frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT takeshiikeuchi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT teiichimotoyama frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT masashikishi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT tadahironagaoka frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT keikohoriuchi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT atsushishiga frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT shujirookuda frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT tomokisekiya frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT ayaohtsubo frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT kosukeichikawa frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT hiroshikagamu frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT toshiakikikuchi frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT satoshiwatanabe frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT junichitanuma frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT peterschraml frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT takaohamakubo frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT masanoritsuchida frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
AT yoichiajioka frequentgermlineandsomaticsinglenucleotidevariantsinthepromoterregionoftheribosomalrnageneinjapaneselungadenocarcinomapatients
_version_ 1724430311339589632
spelling doaj-bbb0d54a6cf148f4a62a2177a1c8183c2020-11-25T04:06:54ZengMDPI AGCells2073-44092020-11-0192409240910.3390/cells9112409Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma PatientsRiuko Ohashi0Hajime Umezu1Ayako Sato2Tatsuya Abé3Shuhei Kondo4Kenji Daigo5Seijiro Sato6Norikazu Hara7Akinori Miyashita8Takeshi Ikeuchi9Teiichi Motoyama10Masashi Kishi11Tadahiro Nagaoka12Keiko Horiuchi13Atsushi Shiga14Shujiro Okuda15Tomoki Sekiya16Aya Ohtsubo17Kosuke Ichikawa18Hiroshi Kagamu19Toshiaki Kikuchi20Satoshi Watanabe21Jun-Ichi Tanuma22Peter Schraml23Takao Hamakubo24Masanori Tsuchida25Yoichi Ajioka26Histopathology Core Facility, Niigata University Faculty of Medicine, Niigata 951-8510, JapanDivision of Pathology, Niigata University Medical & Dental Hospital, Niigata 951-8520, JapanDivision of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDivision of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDivision of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Protein-Protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Kanagawa 211-8533, JapanDivision of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Molecular Genetics, Brain Research Institute, Niigata University, Niigata 951-8510, JapanDepartment of Molecular Genetics, Brain Research Institute, Niigata University, Niigata 951-8510, JapanDepartment of Molecular Genetics, Brain Research Institute, Niigata University, Niigata 951-8510, JapanDivision of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanNeuroscience Laboratory, Research Institute, Nozaki Tokushukai Hospital, Osaka 574-0074, JapanDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science, Fujita Health University, Aichi 470-1192, JapanDepartment of Protein-Protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Kanagawa 211-8533, JapanDepartment of Clinical Laboratory, Niigata Cancer Center hospital, Niigata 951-8560, JapanDivision of Bioinformatics, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanDivision of Oral Pathology, Department of Tissue Regeneration and Reconstruction, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8514, JapanDepartment of Pathology and Molecular Pathology, University of Zurich and University Hospital Zurich, CH-8091 Zurich, SwitzerlandDepartment of Protein-Protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Kanagawa 211-8533, JapanDivision of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, JapanHistopathology Core Facility, Niigata University Faculty of Medicine, Niigata 951-8510, JapanRibosomal RNA (rRNA), the most abundant non-coding RNA species, is a major component of the ribosome. Impaired ribosome biogenesis causes the dysfunction of protein synthesis and diseases called “ribosomopathies,” including genetic disorders with cancer risk. However, the potential role of rRNA gene (rDNA) alterations in cancer is unknown. We investigated germline and somatic single-nucleotide variants (SNVs) in the rDNA promoter region (positions −248 to +100, relative to the transcription start site) in 82 lung adenocarcinomas (LUAC). Twenty-nine tumors (35.4%) carried germline SNVs, and eight tumors (9.8%) harbored somatic SNVs. Interestingly, the presence of germline SNVs between positions +1 and +100 (<i>n</i> = 12; 14.6%) was associated with significantly shorter recurrence-free survival (RFS) and overall survival (OS) by univariate analysis (<i>p</i> < 0.05, respectively), and was an independent prognostic factor for RFS and OS by multivariate analysis. LUAC cell line PC9, carrying rDNA promoter SNV at position +49, showed significantly higher ribosome biogenesis than H1650 cells without SNV. Upon nucleolar stress induced by actinomycin D, PC9 retained significantly higher ribosome biogenesis than H1650. These results highlight the possible functional role of SNVs at specific sites of the rDNA promoter region in ribosome biogenesis, the progression of LUAC, and their potential prognostic value.https://www.mdpi.com/2073-4409/9/11/2409lung adenocarcinomarDNAribosome biogenesissingle nucleotide variantprognosis